Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cell”

491 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 491 results

Early research (Phase 1)Active Not RecruitingNCT05334329
What this trial is testing

Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+8 more
University of California, Irvine 6
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Early research (Phase 1)Study completedNCT03346499
What this trial is testing

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

Who this might be right for
HIV
University of Minnesota 4
Not applicableUnknownNCT01828008
What this trial is testing

Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas

Who this might be right for
Lymphomas
Han weidong 20
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Early research (Phase 1)Active Not RecruitingNCT05020678
What this trial is testing

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Who this might be right for
Lymphoma, Non-HodgkinB-cell Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma+7 more
Nkarta, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00352235
What this trial is testing

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 36
Testing effectiveness (Phase 2)Ended earlyNCT03387085
What this trial is testing

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Early research (Phase 1)Looking for participantsNCT06321484
What this trial is testing

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian CancerRecurrent Ovary CancerOvarian Cancer+4 more
Dana-Farber Cancer Institute 18
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Not applicableStudy completedNCT06320392
What this trial is testing

Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Ain Shams University 90
Testing effectiveness (Phase 2)Looking for participantsNCT05503134
What this trial is testing

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Nationwide Children's Hospital 20
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Not applicableStudy completedNCT01390597
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 32
Testing effectiveness (Phase 2)Study completedNCT02118415
What this trial is testing

Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)

Who this might be right for
NSCLC Stage IIIA/B
Technical University of Munich 13
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Post-approval studies (Phase 4)Study completedNCT01788540
What this trial is testing

Intralipid for Recurrent Miscarriage

Who this might be right for
Abortion, SpontaneousAbortion, Habitual
Woman's Health University Hospital, Egypt 300
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Load More Results